BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38552656)

  • 1. Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study.
    Vahl TP; Thourani VH; Makkar RR; Hamid N; Khalique OK; Daniels D; McCabe JM; Satler L; Russo M; Cheng W; George I; Aldea G; Sheridan B; Kereiakes D; Golwala H; Zahr F; Chetcuti S; Yadav P; Kodali SK; Treede H; Baldus S; Amoroso N; Ranard LS; Pinto DS; Leon MB
    Lancet; 2024 Apr; 403(10435):1451-1459. PubMed ID: 38552656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial.
    Makkar RR; Cheng W; Waksman R; Satler LF; Chakravarty T; Groh M; Abernethy W; Russo MJ; Heimansohn D; Hermiller J; Worthley S; Chehab B; Cunningham M; Matthews R; Ramana RK; Yong G; Ruiz CE; Chen C; Asch FM; Nakamura M; Jilaihawi H; Sharma R; Yoon SH; Pichard AD; Kapadia S; Reardon MJ; Bhatt DL; Fontana GP
    Lancet; 2020 Sep; 396(10252):669-683. PubMed ID: 32593323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The JUPITER registry: One-year outcomes of transapical aortic valve implantation using a second generation transcatheter heart valve for aortic regurgitation.
    Silaschi M; Conradi L; Wendler O; Schlingloff F; Kappert U; Rastan AJ; Baumbach H; Holzhey D; Eichinger W; Bader R; Treede H
    Catheter Cardiovasc Interv; 2018 Jun; 91(7):1345-1351. PubMed ID: 29171730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter aortic valve implantation using the SAPIEN 3 valve to treat aortic regurgitation: The French multicentre S3AR study.
    Delhomme C; Urena M; Zouaghi O; Campelo-Parada F; Ohlmann P; Rioufol G; Van Belle E; Pinaud F; Meneveau N; Staat P; Morel O; Derimay F; Vincent F; Rouleau F; Brochet E; Chong-Nguyen C; Himbert D
    Arch Cardiovasc Dis; 2023 Feb; 116(2):98-105. PubMed ID: 36707263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial.
    Lanz J; Kim WK; Walther T; Burgdorf C; Möllmann H; Linke A; Redwood S; Thilo C; Hilker M; Joner M; Thiele H; Conzelmann L; Conradi L; Kerber S; Schymik G; Prendergast B; Husser O; Stortecky S; Heg D; Jüni P; Windecker S; Pilgrim T;
    Lancet; 2019 Nov; 394(10209):1619-1628. PubMed ID: 31570258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis.
    Thourani VH; Kodali S; Makkar RR; Herrmann HC; Williams M; Babaliaros V; Smalling R; Lim S; Malaisrie SC; Kapadia S; Szeto WY; Greason KL; Kereiakes D; Ailawadi G; Whisenant BK; Devireddy C; Leipsic J; Hahn RT; Pibarot P; Weissman NJ; Jaber WA; Cohen DJ; Suri R; Tuzcu EM; Svensson LG; Webb JG; Moses JW; Mack MJ; Miller DC; Smith CR; Alu MC; Parvataneni R; D'Agostino RB; Leon MB
    Lancet; 2016 May; 387(10034):2218-25. PubMed ID: 27053442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transapical transcatheter aortic valve implantation using a new second-generation TAVI system - J-Valve™ for high-risk patients with aortic valve diseases: Initial results with 90-day follow-up.
    Zhu D; Chen Y; Guo Y; Hu J; Zhang J; Wei X; Tang H; Shi Y
    Int J Cardiol; 2015 Nov; 199():155-62. PubMed ID: 26197402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
    Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
    Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Transcatheter Aortic Valve Replacement in the Treatment of Pure Aortic Regurgitation in Native Valves and Failing Surgical Bioprostheses: Results From an International Registry Study.
    Sawaya FJ; Deutsch MA; Seiffert M; Yoon SH; Codner P; Wickramarachchi U; Latib A; Petronio AS; Rodés-Cabau J; Taramasso M; Spaziano M; Bosmans J; Biasco L; Mylotte D; Savontaus M; Gheeraert P; Chan J; Jørgensen TH; Sievert H; Mocetti M; Lefèvre T; Maisano F; Mangieri A; Hildick-Smith D; Kornowski R; Makkar R; Bleiziffer S; Søndergaard L; De Backer O
    JACC Cardiovasc Interv; 2017 May; 10(10):1048-1056. PubMed ID: 28521923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter aortic valve implantation of a second-generation valve for pure aortic regurgitation: procedural outcome, haemodynamic data and follow-up.
    Schlingloff F; Schäfer U; Frerker C; Schmoeckel M; Bader R
    Interact Cardiovasc Thorac Surg; 2014 Sep; 19(3):388-93. PubMed ID: 24893871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The JUPITER registry: 1-year results of transapical aortic valve implantation using a second-generation transcatheter heart valve in patients with aortic stenosis.
    Silaschi M; Treede H; Rastan AJ; Baumbach H; Beyersdorf F; Kappert U; Eichinger W; Rüter F; de Kroon TL; Lange R; Ensminger S; Wendler O
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):874-881. PubMed ID: 27242354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter Aortic Valve Replacement for Isolated Aortic Regurgitation Using a New Self-Expanding TAVR System.
    Adam M; Tamm AR; Wienemann H; Unbehaun A; Klein C; Arnold M; Marwan M; Theiss H; Braun D; Bleiziffer S; Geyer M; Goncharov A; Kuhn E; Falk V; von Bardeleben RS; Achenbach S; Massberg S; Baldus S; Treede H; Rudolph TK
    JACC Cardiovasc Interv; 2023 Aug; 16(16):1965-1973. PubMed ID: 37648344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial.
    Pibarot P; Salaun E; Dahou A; Avenatti E; Guzzetti E; Annabi MS; Toubal O; Bernier M; Beaudoin J; Ong G; Ternacle J; Krapf L; Thourani VH; Makkar R; Kodali SK; Russo M; Kapadia SR; Malaisrie SC; Cohen DJ; Leipsic J; Blanke P; Williams MR; McCabe JM; Brown DL; Babaliaros V; Goldman S; Szeto WY; Généreux P; Pershad A; Alu MC; Xu K; Rogers E; Webb JG; Smith CR; Mack MJ; Leon MB; Hahn RT;
    Circulation; 2020 May; 141(19):1527-1537. PubMed ID: 32272848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter management of pure native aortic valve regurgitation in patients with left ventricular assist device.
    Hinkov H; Lee CB; Pitts L; Lanmüller P; Klein C; Kukucka M; Potapov E; Kempfert J; Falk V; Dreger H; Unbehaun A
    Eur J Cardiothorac Surg; 2024 Mar; 65(3):. PubMed ID: 38273702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical Bioprostheses.
    Deeb GM; Chetcuti SJ; Reardon MJ; Patel HJ; Grossman PM; Schreiber T; Forrest JK; Bajwa TK; O'Hair DP; Petrossian G; Robinson N; Katz S; Hartman A; Dauerman HL; Schmoker J; Khabbaz K; Watson DR; Yakubov SJ; Oh JK; Li S; Kleiman NS; Adams DH; Popma JJ
    JACC Cardiovasc Interv; 2017 May; 10(10):1034-1044. PubMed ID: 28521921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Transcatheter Aortic Valve Implantation vs Surgical Aortic Valve Replacement on All-Cause Mortality in Patients With Aortic Stenosis: A Randomized Clinical Trial.
    ; Toff WD; Hildick-Smith D; Kovac J; Mullen MJ; Wendler O; Mansouri A; Rombach I; Abrams KR; Conroy SP; Flather MD; Gray AM; MacCarthy P; Monaghan MJ; Prendergast B; Ray S; Young CP; Crossman DC; Cleland JGF; de Belder MA; Ludman PF; Jones S; Densem CG; Tsui S; Kuduvalli M; Mills JD; Banning AP; Sayeed R; Hasan R; Fraser DGW; Trivedi U; Davies SW; Duncan A; Curzen N; Ohri SK; Malkin CJ; Kaul P; Muir DF; Owens WA; Uren NG; Pessotto R; Kennon S; Awad WI; Khogali SS; Matuszewski M; Edwards RJ; Ramesh BC; Dalby M; Raja SG; Mariscalco G; Lloyd C; Cox ID; Redwood SR; Gunning MG; Ridley PD
    JAMA; 2022 May; 327(19):1875-1887. PubMed ID: 35579641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transapical transcatheter aortic valve replacement for aortic regurgitation with a second-generation heart valve.
    Liu H; Yang Y; Wang W; Zhu D; Wei L; Guo K; Zhao W; Yang X; Zhu L; Guo Y; Wang W; Wang C
    J Thorac Cardiovasc Surg; 2018 Jul; 156(1):106-116. PubMed ID: 29525255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantation and 30-Day Follow-Up on All 4 Valve Sizes Within the Portico Transcatheter Aortic Bioprosthetic Family.
    Möllmann H; Linke A; Holzhey DM; Walther T; Manoharan G; Schäfer U; Heinz-Kuck K; Van Boven AJ; Redwood SR; Kovac J; Butter C; Søndergaard L; Lauten A; Schymik G; Worthley SG
    JACC Cardiovasc Interv; 2017 Aug; 10(15):1538-1547. PubMed ID: 28797431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-Year Outcomes of the CENTERA-EU Trial Assessing a Novel Self-Expanding Transcatheter Heart Valve.
    Tchétché D; Windecker S; Kasel AM; Schaefer U; Worthley S; Linke A; Abdel-Wahab M; Le Breton H; Søndergaard L; Spence MS; Petronio S; Baumgartner H; Hovorka T; Blanke P; Reichenspurner H
    JACC Cardiovasc Interv; 2019 Apr; 12(7):673-680. PubMed ID: 30947942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial.
    Thiele H; Kurz T; Feistritzer HJ; Stachel G; Hartung P; Eitel I; Marquetand C; Nef H; Doerr O; Lauten A; Landmesser U; Abdel-Wahab M; Sandri M; Holzhey D; Borger M; Ince H; Öner A; Meyer-Saraei R; Wienbergen H; Fach A; Frey N; König IR; Vonthein R; Rückert Y; Funkat AK; de Waha-Thiele S; Desch S
    Eur Heart J; 2020 May; 41(20):1890-1899. PubMed ID: 32049283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.